|4Dec 20, 5:06 PM ET

Fry Simon Jeremy 4

4 · CONDUIT PHARMACEUTICALS INC. · Filed Dec 20, 2024

Insider Transaction Report

Form 4
Period: 2024-12-18
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-12-18$0.07/sh+420,000$29,820420,000 total
    Exercise: $0.07Exp: 2034-12-18Common Stock (420,000 underlying)
Footnotes (2)
  • [F1]Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2024 annual meeting of stockholders.
  • [F2]The options will vest in equal annual installments on the first three anniversaries of the grant date.

Documents

1 file
  • 4
    ownership.xmlPrimary